fbpx

Research Reports

A Machine

Valeant Pharmaceuticals (VRX) continues to surge ahead, with profit growth expected to surpass 50% later this year. VRX stock is a bargain at 22x earnings and is one of my top holdings.

Read More »

Earnings

Not a member? Sign up here for $25 a month.